1. Home
  2. IPSC vs SIF Comparison

IPSC vs SIF Comparison

Compare IPSC & SIF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IPSC
  • SIF
  • Stock Information
  • Founded
  • IPSC 2019
  • SIF 1913
  • Country
  • IPSC United States
  • SIF United States
  • Employees
  • IPSC N/A
  • SIF N/A
  • Industry
  • IPSC Medicinal Chemicals and Botanical Products
  • SIF Office Equipment/Supplies/Services
  • Sector
  • IPSC Health Care
  • SIF Industrials
  • Exchange
  • IPSC Nasdaq
  • SIF Nasdaq
  • Market Cap
  • IPSC 43.2M
  • SIF 44.2M
  • IPO Year
  • IPSC 2021
  • SIF N/A
  • Fundamental
  • Price
  • IPSC $0.56
  • SIF $7.30
  • Analyst Decision
  • IPSC Strong Buy
  • SIF
  • Analyst Count
  • IPSC 5
  • SIF 0
  • Target Price
  • IPSC $3.33
  • SIF N/A
  • AVG Volume (30 Days)
  • IPSC 486.6K
  • SIF 20.8K
  • Earning Date
  • IPSC 11-04-2025
  • SIF 08-14-2025
  • Dividend Yield
  • IPSC N/A
  • SIF N/A
  • EPS Growth
  • IPSC N/A
  • SIF N/A
  • EPS
  • IPSC N/A
  • SIF N/A
  • Revenue
  • IPSC $114,128,000.00
  • SIF $83,663,000.00
  • Revenue This Year
  • IPSC $1,589.94
  • SIF N/A
  • Revenue Next Year
  • IPSC N/A
  • SIF N/A
  • P/E Ratio
  • IPSC N/A
  • SIF N/A
  • Revenue Growth
  • IPSC 5491.77
  • SIF 35.71
  • 52 Week Low
  • IPSC $0.34
  • SIF $2.33
  • 52 Week High
  • IPSC $1.83
  • SIF $7.88
  • Technical
  • Relative Strength Index (RSI)
  • IPSC 60.86
  • SIF 58.59
  • Support Level
  • IPSC $0.48
  • SIF $6.84
  • Resistance Level
  • IPSC $0.51
  • SIF $7.25
  • Average True Range (ATR)
  • IPSC 0.03
  • SIF 0.33
  • MACD
  • IPSC 0.01
  • SIF -0.05
  • Stochastic Oscillator
  • IPSC 67.79
  • SIF 67.52

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

About SIF SIFCO Industries Inc.

SIFCO Industries Inc is engaged in the production of forgings and machined components for the Aerospace and Energy, Defense and Commercial Space markets. Its processes and services include forging, heat-treating and machining. It serves original equipment manufacturers (OEM) as well as aftermarket customers. Its products are made of steel, stainless steel, titanium and aluminium and include OEM and aftermarket components for aircraft and industrial gas turbine engines, steam turbine blades, structural airframe components, aircraft landing gear components, aircraft wheels and brakes, critical rotating components for helicopters and industrial products. Substantial revenue is derived from North America as well as operates in Europe.

Share on Social Networks: